BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33583697)

  • 1. Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer.
    Chesnut GT; Tin AL; Sivaraman A; Takeda T; Lee T; Fainberg J; Benfante N; Sjoberg DD; Vargas HA; Fine SW; Scardino PT; Eastham JA; Coleman JA; Touijer KA; Zelefsky MJ; Ehdaie B
    Urol Oncol; 2021 Aug; 39(8):495.e17-495.e24. PubMed ID: 33583697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomes.
    Qaoud Y; Herrera-Caceres JO; Bass R; Berjaoui MB; Tiwari R; Kenk M; Lajkosz K; Finelli A; Perlis N; Klotz L; Fleshner N
    Urol Oncol; 2022 Jul; 40(7):343.e1-343.e6. PubMed ID: 35537905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraprostatic Cancer Recurrence following Radical Radiotherapy on Transperineal Template Mapping Biopsy: Implications for Focal Ablative Salvage Therapy.
    Kanthabalan A; Arya M; Freeman A; Mitra AV; Payne H; Peters M; Shah TT; Emberton M; Ahmed HU
    J Urol; 2020 Nov; 204(5):950-955. PubMed ID: 32602770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage therapy for locally recurrent prostate cancer after radiation.
    Marcus DM; Canter DJ; Jani AB; Dobbs RW; Schuster DM; Carthon BC; Rossi PJ
    Can J Urol; 2012 Dec; 19(6):6534-41. PubMed ID: 23228288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage Local Treatments After Focal Therapy for Prostate Cancer.
    Marra G; Valerio M; Emberton M; Heidenreich A; Crook JM; Bossi A; Pisters LL
    Eur Urol Oncol; 2019 Sep; 2(5):526-538. PubMed ID: 31412013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial.
    Light A; Kanthabalan A; Otieno M; Pavlou M; Omar R; Adeleke S; Giganti F; Brew-Graves C; Williams NR; Emara A; Haroon A; Latifoltojar A; Sidhu H; Freeman A; Orczyk C; Nikapota A; Dudderidge T; Hindley RG; Virdi J; Arya M; Payne H; Mitra AV; Bomanji J; Winkler M; Horan G; Moore CM; Emberton M; Punwani S; Ahmed HU; Shah TT
    Eur Urol; 2024 Jan; 85(1):35-46. PubMed ID: 37778954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triggers and oncologic outcome of salvage radical prostatectomy, salvage radiotherapy and active surveillance after focal therapy of prostate cancer.
    von Hardenberg J; Cash H; Koch D; Borkowetz A; Bruendl J; Leyh-Bannurah SR; Kuru TH; Kowalewski KF; Schindele D; Mala KS; Westhoff N; Blana A; Schostak M;
    World J Urol; 2021 Oct; 39(10):3747-3754. PubMed ID: 33881557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seminal vesicle involvement at salvage radical prostatectomy.
    Meeks JJ; Walker M; Bernstein M; Eastham JA
    BJU Int; 2013 Jun; 111(8):E342-7. PubMed ID: 23495695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
    Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
    Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topography of Prostate Cancer Recurrence: A Single-centre Analysis of Salvage Radical Prostatectomy Specimens and Implications for Focal Salvage Treatments.
    Marra G; Calleris G; Massari E; Vissio E; Molinaro L; Cassoni P; D'Agate D; Oderda M; Valerio M; Raskin Y; Joniau S; Papotti M; Gontero P
    Eur Urol Open Sci; 2023 Jan; 47():110-118. PubMed ID: 36601045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of post-radiotherapy biopsy before salvage radical prostatectomy.
    Meeks JJ; Walker M; Bernstein M; Kent M; Eastham JA
    BJU Int; 2013 Aug; 112(3):308-12. PubMed ID: 23490232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal versus whole gland salvage brachytherapy for recurrent prostate cancer in the prostate specific membrane antigen PET era: a narrative review.
    Andring LM; Teh BS; Butler EB; Farach AM
    Chin Clin Oncol; 2023 Jun; 12(3):26. PubMed ID: 37417290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy.
    Heidenreich A; Richter S; Thüer D; Pfister D
    Eur Urol; 2010 Mar; 57(3):437-43. PubMed ID: 19303197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage open radical prostatectomy for recurrent prostate cancer following MRI-guided transurethral ultrasound ablation (TULSA) of the prostate: feasibility and efficacy.
    Nair SM; Stern N; Dewar M; Siddiqui K; Smith E; Gomez JA; Moussa M; Chin JL
    Scand J Urol; 2020 Jun; 54(3):215-219. PubMed ID: 32308085
    [No Abstract]   [Full Text] [Related]  

  • 15. Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After Radiotherapy.
    Shah TT; Kanthabalan A; Otieno M; Pavlou M; Omar R; Adeleke S; Giganti F; Brew-Graves C; Williams NR; Grierson J; Miah H; Emara A; Haroon A; Latifoltojar A; Sidhu H; Clemente J; Freeman A; Orczyk C; Nikapota A; Dudderidge T; Hindley RG; Virdi J; Arya M; Payne H; Mitra A; Bomanji J; Winkler M; Horan G; Moore CM; Emberton M; Punwani S; Ahmed HU
    Eur Urol; 2022 Jun; 81(6):598-605. PubMed ID: 35370021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal MRI-Guided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer.
    Maenhout M; Peters M; van Vulpen M; Moerland MA; Meijer RP; van den Bosch MAAJ; Nguyen PL; Frank SJ; van der Voort van Zyp JRN
    Technol Cancer Res Treat; 2017 Dec; 16(6):1194-1201. PubMed ID: 29333958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological characteristics of prostate cancer recurrence after radiation therapy: implications for focal salvage therapy.
    Leibovici D; Chiong E; Pisters LL; Guo CC; Ward JF; Andino L; Prokhorova IN; Troncoso P
    J Urol; 2012 Jul; 188(1):98-102. PubMed ID: 22578724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage low-dose-rate brachytherapy for prostate cancer local recurrence after radical prostatectomy: our first three patients.
    Gastaldi E; Gallo F; Chiono L; Giberti C
    Urologia; 2014; 81(1):46-50. PubMed ID: 24474541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging.
    Linder BJ; Kawashima A; Woodrum DA; Tollefson MK; Karnes J; Davis BJ; Rangel LJ; King BF; Mynderse LA
    Can J Urol; 2014 Jun; 21(3):7283-9. PubMed ID: 24978358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical Trial.
    Murgic J; Morton G; Loblaw A; D'Alimonte L; Ravi A; Wronski M; Davidson M; Haider M; Commisso K; Zhang L; Chung HT
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):561-567. PubMed ID: 30244878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.